logotyp Student Portal
Web page

Master Programme in Molecular Medicine

Master project Molecular Medicine vt16

Master project presentations 

Master in Molecular Medicine   2016


31th May BMC A1:107    (10.50- upload presentations)


11.00 -11.45      Combined inhibition of MYC and MYCN in human glioblastoma multiforme

 Speaker: Lisa Franziska Drews, Uppsala University               


11.45- 12.30 MMNR2: a novel interacting partner of CD93 required for endothelial cell dynamics

Speaker: Kalyani Vemuri, Uppsala University               





13.20- 14.05 Optimization of Highly Throughput Single Cell Transcriptomics Setup

Speaker: Abeer Heskol, Karolinska Institute        


14.15- 15.00 Evaulating Various Combinatorial Therapeutic Platform for Personilzed Medicine

Speaker: Sara Svensson Akusjärvi, Karolinska Institute   (Skype)


Coffee break


15.15- 16.00 Zebrafish as a model system to investigate heart rhythm

Speaker: Silvia Vicenzi, Uppsala University


16.00-16.45 Comparative bioinformatic analysis of DNA methylation and H3K27me3 in multiple myeloma

Speaker: Aron T. Skaftason               


17.00         -17.45 CRISPR-Cas9 dissection of cis-acting 
sequences regulating foetal haemoglobin level-associated BCL11A

Speaker: Gilbert Siame, Harvard  (Skype)


1 June BMC A1:107                           (9.50- upload presentations)


10.00-10.45  Applying a tagmentation approach  ChIPmentation for histone modification profiling in ALL

Speaker:Aikaterini  Mechtidou, Uppsala University              


11.00 -11.45 Defining the metabolic changes in cancer cells with mutant p53

Speaker: Dominique Smith, Karolinska Institute 





13.00- 13.45 Generation of differentiated motor neurons from iPSCs and effect of injected mesoporous silica nanoparticles into the spinal cord

Speaker: Ropafadzo Mzezewa, Uppsala University                    


13.45-14.30 Genome Engineering utilizing CRISPR-Cpf1 in HEK293T cells

Speaker: Nerges Winblad, Broad Institute                    


Coffee break


15.00-15.45 Phenotypic analysis of tumors undergoing immunotherapy

Speaker: Anna Höfges, University of Wisconsin, Madison

  (Skype 8-9 am with Unv Madison)


Coffee break


16.30-17.15 The role of the epithelial-mesenchymal transition (EMT) in cancer metabolism

Speaker: Lidia Moyano Galceran, MIT

(Skype 10.30 am with MIT)


2 June BMC A1:107         (8.50- upload presentations)


9.00-9.45 Developing Semliki Forest virus as oncolytic agent for cancer therapy

Speaker:Tina Sarén, Uppsala University                       


Coffee break


10.00- 10.45 Triggering DNA methylation changes in colorectal cancer cell line upon BRAF mutation induction

Speaker: Bettina Zimmerman, University of Basel                

10.45- 12.00 Program evaluation